Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines

G. L. Gessa, P. F. Spano, L. Vargiu, F. Crabai, A. Tagliamonte, L. Mameli

Research output: Contribution to journalArticle

Abstract

Many butyric acid congeners were screened for their behavioural effect and for their influence on brain amines. Among the compounds examined, all butyric acid derivatives endowed with depressant action on the CNS, and only those endowed with such action, were capable of increasing selectively brain DA. Brain NE and serotonin were not influenced. Besides {A figure is presented}-OH and {A figure is presented}-BL, the following compounds were found to be active: 1,4-BD, α-OH-butyric acid, {A figure is presented}-BL- {A figure is presented}-carboxylic acid and succinate. 1,4-BD was studied in detail in rats and in rabbits. The effect of this compound shows close similiarities to that of {A figure is presented}-OH. There is a direct correlation between the degree of sedation produced by this compound an the accumulation of DA in the brain. This is particularly evident in rabbits: the anaesthetic effect occurs after a delay of about two hours, as does the rise in brain DA. The DA levels return to normal when the animals are awake. The newly-formed DA is localized in the pallidum and in the striatum. The mechanism by which the above compounds, and specifically 1,4-BD, produce the change in brain DA is not clear: 1,4-BD, like {A figure is presented}-OH, does not inhibit MAO either in vivo or in vitro. The fact that 1,4-BD produces its effect after a long delay suggests that it acts through an active metabolite.

Original languageEnglish
Pages (from-to)289-298
Number of pages10
JournalLife Sciences
Volume7
Issue number5
Publication statusPublished - Mar 1 1968

Fingerprint

Butyric Acid
Catecholamines
Brain
Rabbits
Globus Pallidus
Monoamine Oxidase
Succinic Acid
Metabolites
Carboxylic Acids
Amines
Anesthetics
1,4-butanediol
Rats
Serotonin
Animals
Derivatives

ASJC Scopus subject areas

  • Pharmacology

Cite this

Gessa, G. L., Spano, P. F., Vargiu, L., Crabai, F., Tagliamonte, A., & Mameli, L. (1968). Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines. Life Sciences, 7(5), 289-298.

Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines. / Gessa, G. L.; Spano, P. F.; Vargiu, L.; Crabai, F.; Tagliamonte, A.; Mameli, L.

In: Life Sciences, Vol. 7, No. 5, 01.03.1968, p. 289-298.

Research output: Contribution to journalArticle

Gessa, GL, Spano, PF, Vargiu, L, Crabai, F, Tagliamonte, A & Mameli, L 1968, 'Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines', Life Sciences, vol. 7, no. 5, pp. 289-298.
Gessa GL, Spano PF, Vargiu L, Crabai F, Tagliamonte A, Mameli L. Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines. Life Sciences. 1968 Mar 1;7(5):289-298.
Gessa, G. L. ; Spano, P. F. ; Vargiu, L. ; Crabai, F. ; Tagliamonte, A. ; Mameli, L. / Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines. In: Life Sciences. 1968 ; Vol. 7, No. 5. pp. 289-298.
@article{45342f436a69426faff06cc21a250c7c,
title = "Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines",
abstract = "Many butyric acid congeners were screened for their behavioural effect and for their influence on brain amines. Among the compounds examined, all butyric acid derivatives endowed with depressant action on the CNS, and only those endowed with such action, were capable of increasing selectively brain DA. Brain NE and serotonin were not influenced. Besides {A figure is presented}-OH and {A figure is presented}-BL, the following compounds were found to be active: 1,4-BD, α-OH-butyric acid, {A figure is presented}-BL- {A figure is presented}-carboxylic acid and succinate. 1,4-BD was studied in detail in rats and in rabbits. The effect of this compound shows close similiarities to that of {A figure is presented}-OH. There is a direct correlation between the degree of sedation produced by this compound an the accumulation of DA in the brain. This is particularly evident in rabbits: the anaesthetic effect occurs after a delay of about two hours, as does the rise in brain DA. The DA levels return to normal when the animals are awake. The newly-formed DA is localized in the pallidum and in the striatum. The mechanism by which the above compounds, and specifically 1,4-BD, produce the change in brain DA is not clear: 1,4-BD, like {A figure is presented}-OH, does not inhibit MAO either in vivo or in vitro. The fact that 1,4-BD produces its effect after a long delay suggests that it acts through an active metabolite.",
author = "Gessa, {G. L.} and Spano, {P. F.} and L. Vargiu and F. Crabai and A. Tagliamonte and L. Mameli",
year = "1968",
month = "3",
day = "1",
language = "English",
volume = "7",
pages = "289--298",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effect of 1,4-butanediol and other butyric acid congeners on brain catecholamines

AU - Gessa, G. L.

AU - Spano, P. F.

AU - Vargiu, L.

AU - Crabai, F.

AU - Tagliamonte, A.

AU - Mameli, L.

PY - 1968/3/1

Y1 - 1968/3/1

N2 - Many butyric acid congeners were screened for their behavioural effect and for their influence on brain amines. Among the compounds examined, all butyric acid derivatives endowed with depressant action on the CNS, and only those endowed with such action, were capable of increasing selectively brain DA. Brain NE and serotonin were not influenced. Besides {A figure is presented}-OH and {A figure is presented}-BL, the following compounds were found to be active: 1,4-BD, α-OH-butyric acid, {A figure is presented}-BL- {A figure is presented}-carboxylic acid and succinate. 1,4-BD was studied in detail in rats and in rabbits. The effect of this compound shows close similiarities to that of {A figure is presented}-OH. There is a direct correlation between the degree of sedation produced by this compound an the accumulation of DA in the brain. This is particularly evident in rabbits: the anaesthetic effect occurs after a delay of about two hours, as does the rise in brain DA. The DA levels return to normal when the animals are awake. The newly-formed DA is localized in the pallidum and in the striatum. The mechanism by which the above compounds, and specifically 1,4-BD, produce the change in brain DA is not clear: 1,4-BD, like {A figure is presented}-OH, does not inhibit MAO either in vivo or in vitro. The fact that 1,4-BD produces its effect after a long delay suggests that it acts through an active metabolite.

AB - Many butyric acid congeners were screened for their behavioural effect and for their influence on brain amines. Among the compounds examined, all butyric acid derivatives endowed with depressant action on the CNS, and only those endowed with such action, were capable of increasing selectively brain DA. Brain NE and serotonin were not influenced. Besides {A figure is presented}-OH and {A figure is presented}-BL, the following compounds were found to be active: 1,4-BD, α-OH-butyric acid, {A figure is presented}-BL- {A figure is presented}-carboxylic acid and succinate. 1,4-BD was studied in detail in rats and in rabbits. The effect of this compound shows close similiarities to that of {A figure is presented}-OH. There is a direct correlation between the degree of sedation produced by this compound an the accumulation of DA in the brain. This is particularly evident in rabbits: the anaesthetic effect occurs after a delay of about two hours, as does the rise in brain DA. The DA levels return to normal when the animals are awake. The newly-formed DA is localized in the pallidum and in the striatum. The mechanism by which the above compounds, and specifically 1,4-BD, produce the change in brain DA is not clear: 1,4-BD, like {A figure is presented}-OH, does not inhibit MAO either in vivo or in vitro. The fact that 1,4-BD produces its effect after a long delay suggests that it acts through an active metabolite.

UR - http://www.scopus.com/inward/record.url?scp=0014266259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014266259&partnerID=8YFLogxK

M3 - Article

C2 - 5641721

AN - SCOPUS:0014266259

VL - 7

SP - 289

EP - 298

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -